The ArcheMedX team is energized to attend the annual SCOPE Summit of Clinical Operations Executives in Orlando, FL, February 6 – 9.
Trial sponsors recognize site initiation processes often lead to excessive delays but have struggled to adapt and improve. Connect with ArcheMedX at SCOPE and meet Ready, the only clinical trial team learning and predictive analytics platform that optimizes trial delivery and accelerates timelines.
Learn how ArcheMedX provides a novel approach to site activation that minimizes delays by delivering better training that predicts and improves site performance, reducing time spent in SIVs by 90%.
On Tuesday, February 7th at 2:35pm, join our CEO, Joel Selzer, to learn how trial sponsors and CROs can change trial team behavior to reduce study team burden, accelerate activation timelines, and minimize downstream trial risk during the Lean ClinOps for Small Biopharma track.
Related Post
AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The risk in an AI-first trial is not that teams use the tools. It is…
Joel Selzer
The Earliest Warning Sign: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
Most protocol deviations start as human problems, not operational ones, but risk-based monitoring typically relies…
Brian S McGowan, PhD
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
By leveraging the Fresh Start Effect at site initiation and shifting from passive training to…
